To receive all of AFYREN’s financial information in real time, send a request by email to [email protected]
– Industrial commissioning of AFYREN NEOXY initiated in March, in line with the schedule and budget announced
– Net income of – €4.2 million in line with the development plan announced during the IPO (start-up of the first plant in progress and preparation of the next ones)
– Securing the sale of 70% of the anticipated production of organic acids from the AFYREN NEOXY plant, thanks to numerous strategic contracts in all of AFYREN’s priority markets